iSpecimen shares surge 24.39% premarket after insider Benjamin Bielak acquires 18,000 shares.

iSpecimen (ISPC) surged 24.39% in premarket trading, driven by insider buying as Benjamin Bielak acquired 18,000 shares on September 16. The transaction, reported at 8:58 AM, occurred during the premarket window and signaled confidence in the company’s prospects, potentially boosting investor sentiment. While other recent developments—such as workforce reductions and operational restructuring—were bearish, they were outweighed by the immediate positive signal from insider activity. The stock’s sharp premarket rise aligns with the timing and nature of the insider purchase, which is often interpreted as a vote of confidence in the company’s strategic direction.